Guardant Health
GH
#1485
Rank
C$19.66 B
Marketcap
C$151.41
Share price
2.42%
Change (1 day)
182.31%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: C$19.66 Billion

As of December 2025 Guardant Health has a market cap of C$19.66 Billion. This makes Guardant Health the world's 1485th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025C$19.66 B264.36%
2024C$5.39 B23.93%
2023C$4.35 B15.18%
2022C$3.78 B-70.82%
2021C$12.95 B-21.12%
2020C$16.42 B71.42%
2019C$9.58 B118.25%
2018C$4.39 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Guardant Health was reported to be:

C$19.08 Billion
by Nasdaq info icon info icon
C$19.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Natera
NTRA
C$46.61 B 137.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
C$1.79 B-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA